Ellerhorst JA - Search Results

1

Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma.

Ellerhorst JA, Bedikian AY, Smith TM, Papadopoulos NE, Plager C, Eton O. Ellerhorst JA, et al. Anticancer Drugs. 2002 Feb;13(2):169-72. doi: 10.1097/00001813-200202000-00009. Anticancer Drugs. 2002. PMID: 11901310 Clinical Trial.

2

Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma.

Bedikian AY, Plager C, Papadopoulos N, Eton O, Ellerhorst J, Smith T. Bedikian AY, et al. Melanoma Res. 2004 Feb;14(1):63-6. doi: 10.1097/00008390-200402000-00010. Melanoma Res. 2004. PMID: 15091196 Clinical Trial.

3

Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.

Ellerhorst JA, Bedikian A, Ring S, Buzaid AC, Eton O, Legha SS. Ellerhorst JA, et al. Oncol Rep. 1999 Sep-Oct;6(5):1097-9. doi: 10.3892/or.6.5.1097. Oncol Rep. 1999. PMID: 10425308 Clinical Trial.

4

A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy.

Eton O, Buzaid AC, Bedikian AY, Smith TM, Papadopoulos NE, Ellerhorst JA, Hibberts JL, Legha SS, Benjamin RS. Eton O, et al. Among authors: ellerhorst ja. Cancer. 2000 Apr 1;88(7):1703-9. Cancer. 2000. PMID: 10738230 Clinical Trial.

5

A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanoma.

Bedikian AY, Plager C, Papadopoulos N, Ellerhorst J, Smith T, Benjamin RS. Bedikian AY, et al. Oncol Rep. 2000 Jul-Aug;7(4):883-6. doi: 10.3892/or.7.4.883. Oncol Rep. 2000. PMID: 10854563 Clinical Trial.

6

Phase II evaluation of bryostatin-1 in metastatic melanoma.

Bedikian AY, Plager C, Stewart JR, O'Brian CA, Herdman SK, Ross M, Papadopoulos N, Eton O, Ellerhorst J, Smith T. Bedikian AY, et al. Melanoma Res. 2001 Apr;11(2):183-8. doi: 10.1097/00008390-200104000-00014. Melanoma Res. 2001. PMID: 11333129 Clinical Trial.

7

Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma.

Eton O, Ross MI, East MJ, Mansfield PF, Papadopoulos N, Ellerhorst JA, Bedikian AY, Lee JE. Eton O, et al. Among authors: ellerhorst ja. J Transl Med. 2010 Jan 29;8:9. doi: 10.1186/1479-5876-8-9. J Transl Med. 2010. PMID: 20109236 Free PMC article. Clinical Trial.

8

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA. Ibrahim NK, et al. Among authors: ellerhorst ja. Clin Cancer Res. 2002 May;8(5):1038-44. Clin Cancer Res. 2002. PMID: 12006516 Clinical Trial.

9

Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment.

Hwang CS, Prieto VG, Diwan AH, Lizee G, Ellerhorst JA, Ekmekcioglu S, Liu P, Eton O, Kinney SA, Grimm EA, Hwu P, Kim KB. Hwang CS, et al. Among authors: ellerhorst ja. Melanoma Res. 2008 Aug;18(4):241-5. doi: 10.1097/CMR.0b013e3283046146. Melanoma Res. 2008. PMID: 18626307 Free PMC article. Clinical Trial.

10

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.

Logothetis CJ, Finn LD, Smith T, Kilbourn RG, Ellerhorst JA, Zukiwski AA, Sella A, Tu SM, Amato RJ. Logothetis CJ, et al. Among authors: ellerhorst ja. J Clin Oncol. 1995 Sep;13(9):2272-7. doi: 10.1200/JCO.1995.13.9.2272. J Clin Oncol. 1995. PMID: 7666085 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters